Australian Federal Court Rules For Patent Over Breast Cancer Gene

Bulldust writes “The Federal Court in Australia has ruled in favor of U.S. biotechnology company Myriad Genetics, enabling them to continue to hold the patent over the so-called breast cancer gene BRCA1. The same patent is also being reconsidered by the U.S. Supreme Court in the current session. From the article: ‘Federal court Justice John Nicholas has ruled that a private company can continue to hold a patent over the so-called breast cancer gene BRCA1, in a decision that has devastated cancer victims.The decision is the first in Australia to rule on whether isolated genes can be patented, and will set a precedent in favor of commercial ownership of genetic material.'”

Share on Google+

Read more of this story at Slashdot.

via Slashdot http://science.slashdot.org/story/13/02/15/0155241/australian-federal-court-rules-for-patent-over-breast-cancer-gene?utm_source=rss1.0mainlinkanon&utm_medium=feed

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: